157 related articles for article (PubMed ID: 34097381)
1. Turnover and Inactivation Mechanisms for (
Shen S; Butrin A; Doubleday PF; Melani RD; Beaupre BA; Tavares MT; Ferreira GM; Kelleher NL; Moran GR; Liu D; Silverman RB
J Am Chem Soc; 2021 Jun; 143(23):8689-8703. PubMed ID: 34097381
[TBL] [Abstract][Full Text] [Related]
2. Structural and Mechanistic Basis for the Inactivation of Human Ornithine Aminotransferase by (3
Shen S; Butrin A; Beaupre BA; Ferreira GM; Doubleday PF; Grass DH; Zhu W; Kelleher NL; Moran GR; Liu D; Silverman RB
Molecules; 2023 Jan; 28(3):. PubMed ID: 36770800
[TBL] [Abstract][Full Text] [Related]
3. Remarkable and Unexpected Mechanism for (
Zhu W; Doubleday PF; Butrin A; Weerawarna PM; Melani RD; Catlin DS; Dwight TA; Liu D; Kelleher NL; Silverman RB
J Am Chem Soc; 2021 Jun; 143(21):8193-8207. PubMed ID: 34014654
[TBL] [Abstract][Full Text] [Related]
4. Rational Design, Synthesis, and Mechanism of (3
Zhu W; Butrin A; Melani RD; Doubleday PF; Ferreira GM; Tavares MT; Habeeb Mohammad TS; Beaupre BA; Kelleher NL; Moran GR; Liu D; Silverman RB
J Am Chem Soc; 2022 Mar; 144(12):5629-5642. PubMed ID: 35293728
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Mechanistic Studies of (
Devitt AN; Vargas AL; Zhu W; Des Soye BJ; Butun FA; Alt T; Kaley N; Ferreira GM; Moran GR; Kelleher NL; Liu D; Silverman RB
ACS Chem Biol; 2024 May; 19(5):1066-1081. PubMed ID: 38630468
[TBL] [Abstract][Full Text] [Related]
6. A Remarkable Difference That One Fluorine Atom Confers on the Mechanisms of Inactivation of Human Ornithine Aminotransferase by Two Cyclohexene Analogues of γ-Aminobutyric Acid.
Zhu W; Doubleday PF; Catlin DS; Weerawarna PM; Butrin A; Shen S; Wawrzak Z; Kelleher NL; Liu D; Silverman RB
J Am Chem Soc; 2020 Mar; 142(10):4892-4903. PubMed ID: 32114761
[TBL] [Abstract][Full Text] [Related]
7. Determination of the pH dependence, substrate specificity, and turnovers of alternative substrates for human ornithine aminotransferase.
Butrin A; Butrin A; Wawrzak Z; Moran GR; Liu D
J Biol Chem; 2022 Jun; 298(6):101969. PubMed ID: 35460691
[TBL] [Abstract][Full Text] [Related]
8. Mechanism of Inactivation of Ornithine Aminotransferase by (1
Moschitto MJ; Doubleday PF; Catlin DS; Kelleher NL; Liu D; Silverman RB
J Am Chem Soc; 2019 Jul; 141(27):10711-10721. PubMed ID: 31251613
[TBL] [Abstract][Full Text] [Related]
9. Structural and Kinetic Analyses Reveal the Dual Inhibition Modes of Ornithine Aminotransferase by (1
Butrin A; Beaupre BA; Kadamandla N; Zhao P; Shen S; Silverman RB; Moran GR; Liu D
ACS Chem Biol; 2021 Jan; 16(1):67-75. PubMed ID: 33316155
[TBL] [Abstract][Full Text] [Related]
10. Selective Targeting by a Mechanism-Based Inactivator against Pyridoxal 5'-Phosphate-Dependent Enzymes: Mechanisms of Inactivation and Alternative Turnover.
Mascarenhas R; Le HV; Clevenger KD; Lehrer HJ; Ringe D; Kelleher NL; Silverman RB; Liu D
Biochemistry; 2017 Sep; 56(37):4951-4961. PubMed ID: 28816437
[TBL] [Abstract][Full Text] [Related]
11. Oligomeric State and Thermal Stability of Apo- and Holo- Human Ornithine δ-Aminotransferase.
Montioli R; Zamparelli C; Borri Voltattorni C; Cellini B
Protein J; 2017 Jun; 36(3):174-185. PubMed ID: 28345116
[TBL] [Abstract][Full Text] [Related]
12. Crystal structure of human ornithine aminotransferase complexed with the highly specific and potent inhibitor 5-fluoromethylornithine.
Storici P; Capitani G; Müller R; Schirmer T; Jansonius JN
J Mol Biol; 1999 Jan; 285(1):297-309. PubMed ID: 9878407
[TBL] [Abstract][Full Text] [Related]
13. Ornithine aminotransferase versus GABA aminotransferase: implications for the design of new anticancer drugs.
Lee H; Juncosa JI; Silverman RB
Med Res Rev; 2015 Mar; 35(2):286-305. PubMed ID: 25145640
[TBL] [Abstract][Full Text] [Related]
14. Crystal structure of human recombinant ornithine aminotransferase.
Shen BW; Hennig M; Hohenester E; Jansonius JN; Schirmer T
J Mol Biol; 1998 Mar; 277(1):81-102. PubMed ID: 9514741
[TBL] [Abstract][Full Text] [Related]
15. Properties of crystalline L-ornithine: alpha-ketoglutarate delta-aminotransferase from Bacillus sphaericus.
Yasuda M; Tanizawa K; Misono H; Toyama S; Soda K
J Bacteriol; 1981 Oct; 148(1):43-50. PubMed ID: 7287630
[TBL] [Abstract][Full Text] [Related]
16. An ornithine ω-aminotransferase required for growth in the absence of exogenous proline in the archaeon
Zheng RC; Hachisuka SI; Tomita H; Imanaka T; Zheng YG; Nishiyama M; Atomi H
J Biol Chem; 2018 Mar; 293(10):3625-3636. PubMed ID: 29352105
[TBL] [Abstract][Full Text] [Related]
17. Human ornithine aminotransferase complexed with L-canaline and gabaculine: structural basis for substrate recognition.
Shah SA; Shen BW; Brünger AT
Structure; 1997 Aug; 5(8):1067-75. PubMed ID: 9309222
[TBL] [Abstract][Full Text] [Related]
18. Unique substrate specificity of ornithine aminotransferase from
Astegno A; Maresi E; Bertoldi M; La Verde V; Paiardini A; Dominici P
Biochem J; 2017 Mar; 474(6):939-955. PubMed ID: 28126740
[No Abstract] [Full Text] [Related]
19. Design of potential anticonvulsant agents: mechanistic classification of GABA aminotransferase inactivators.
Nanavati SM; Silverman RB
J Med Chem; 1989 Nov; 32(11):2413-21. PubMed ID: 2681782
[TBL] [Abstract][Full Text] [Related]
20. An investigation of the properties of ornithine aminotransferase after inactivation by the 'suicide' inhibitor aminohexynoate and use of the compound as a probe of intracellullar protein turnover.
Jones ED; Basford JM; John RA
Biochem J; 1983 Jan; 209(1):243-9. PubMed ID: 6847611
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
